Scott is the CEO of Zoe Biosciences, a biotech developing therapeutics for cardiometabolic diseases. Before founding Zoe, he led Business Development & Strategic Partnerships at the Flow Research Collective and advised the Longevity Vision Fund on biotech investments. His research background spans epigenetics and genomics (Sharp Lab, Mount Sinai), octopus cognition (Tse Lab, Dartmouth), computational autism research, and marine conservation in Madagascar. Scott holds a B.A. in Neuroscience from Dartmouth and an M.S. in Biotechnology from Johns Hopkins.